NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue:
Point of Care Diagnostics
Advertisement
http://www.reportlinker.com/p0166822/Point-of-Care-Diagnostics.html
Provides a complete review and analysis of the point of care (POC) diagnostics industry
Advertisement
Includes market forecasts through 2014 for the U.S. POC diagnostics industry
Covers federal regulation of POC testing
Analyzes market influences and predicts the future of POC
Reviews business activities of market leaders
Highlights emerging and leading technologies
Offers a thorough patent analysis.
Chapter- 1: INTRODUCTION -- Complimentary
STUDY GOALS AND OBJECTIVES 1
REASONS FOR DOING THE STUDY 1
SCOPE OF REPORT 1
DEFINING POC 2
METHODOLOGY 2
ANALYST CREDENTIALS 3
RELATED REPORTS 3
BCC ONLINE SERVICES 3
DISCLAIMER 4
Chapter-2: SUMMARY
OVERVIEW 5
MAJOR FINDINGS 5
SUMMARY TABLE FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, THROUGH 2014 ($ MILLIONS) 6
SUMMARY FIGURE FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, 2009 AND 2014 ($ MILLIONS) 7
Chapter-3: INDUSTRY OVERVIEW
WHAT IS POC TESTING? 8
OVERVIEW OF POC MARKET 8
POC AS PART OF CLINICAL DIAGNOSTICS INDUSTRY STRUCTURE 9
MEDICAL BENEFITS DERIVED FROM IMMEDIATE DIAGNOSTIC TESTING 9
POC TESTING SITES 10
TABLE 1 SELECTED KEY STATISTICS FOR POC TESTING SITES 10
HOME USE/SELF-CARE 11
EMERGENCY ROOMS (ER) 11
CRITICAL-CARE UNITS (CCU) 11
BEDSIDE TESTING 12
TABLE 2 NUMBER OF HOSPITALS FOR SELECTED COUNTRIES, 2009 12
OPERATING ROOMS (OR)/PROCEDURE ROOMS (PR) 12
PHYSICIANS OFFICES/ CLINICS/ TREATMENT CENTERS/OTHER NONCRITICAL=CARE SITES 13
TABLE 3 NUMBER OF U.S. HEALTHCARE FACILITIES BY TYPE, 2006* 13
POC PRODUCT SEGMENTS 13
POC CLINICAL ASSAY CATEGORIES 14
Blood Chemistry and Electrolytes 14
Cardiac Marker 14
Cholesterol Testing/Monitoring 14
Drug and Alcohol Screening 15
Glucose Testing and Monitoring 15
Infectious Disease Testing 15
Pregnancy and Fertility Testing 15
Hemoglobin and Hemostasis 16
Tumor Marker 16
Urinalysis/Urine Chemistry 17
COMMONLY PERFORMED POC TESTS 17
TABLE 4 SELECTED POC TESTS - CLIA WAIVED 17
TABLE 4 (CONTINUED) 18
SIGNIFICANCE OF CLIA IN THE UNITED STATES 18
SIGNIFICANCE OF CLIA IN THE UNITED STATES (CONTINUED) 19
OTHER REGULATORY AGENCIES 20
FDA 20
Good Manufacturing Practice (GMP) 20
TABLE 5 PERTINENT PARAMETERS OF GMP REGULATIONS AFFECTING IN VITRO DIAGNOSTICS 21
DRIVING FORCES OF THE POC MARKET 21
COST CONTAINMENT 22
Rising Healthcare Costs 22
TABLE 6 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY, 1980-2006 (%) 22
FIGURE 1 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY, 1980-2006 (%) 23
Average Length of Stay 23
TABLE 7 HOSPITAL USAGE STATISTICS, BY COUNTRY (DAYS) 24
FIGURE 2 HOSPITAL USAGE STATISTICS, BY COUNTRY (DAYS) 24
GLOBAL SHORTAGE OF HEALTHCARE WORKERS 25
TECHNOLOGICAL ADVANCEMENT 25
Availability - Ease of Use Devices 26
New Technologies 26
Biosensors 26
CHANGES IN INCIDENCE OF DISEASE 26
TABLE 8 PREVALENCE OF SELECTED DISEASES IN THE GLOBAL POPULATION, 2008-2009 (MILLION CASES) 27
Asthma 27
Cardiovascular Disease 28
Cancer 28
Diabetes 28
Diarrheal Disease 29
HIV 29
Infertility 29
Influenza 29
Malaria 29
Pregnancy 30
Pulmonary Disease 30
Tuberculosis 30
Aging Population 30
TABLE 9 ESTIMATED WORLD POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS) 31
FIGURE 3 ESTIMATED WORLD POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS) 31
TABLE 10 WORLD POPULATION BY SELECTED COUNTRY, THROUGH 2014 (MILLIONS) 32
FIGURE 4 WORLD POPULATION BY SELECTED COUNTRY, 2007-2014 (MILLIONS) 33
Chapter-4: THE POC MARKET
MARKET OVERVIEW 34
TABLE 11 GLOBAL FORECAST FOR THE POC MARKET BY SEGMENT, THROUGH 2014 ($ MILLIONS) 34
FIGURE 5 GLOBAL FORECAST FOR THE POC MARKET BY SEGMENT, 2007-2014 ($ MILLIONS) 35
COMPETITOR MARKET SHARE 35
COMPETITOR MARKET SHARE (CONTINUED) 36
TABLE 12 MARKET SHARE OF POC MARKET PARTICIPANTS, 2009 (PERCENT/$ MILLIONS) 37
MARKET SHARE OF POC MARKET PARTICIPANTS, 2009 (%) 38
MARKET STRUCTURE 38
DISTRIBUTION 38
FIGURE 7 DISTRIBUTION CHANNELS: POC DIAGNOSTIC DEVICES 39
PROMOTION 39
STRATEGIC ALLIANCES AND MERGERS 39
MARKET COMPONENTS 40
BLOOD CHEMISTRY AND ELECTROLYTE TESTING 41
Blood Chemistry Parameters 41
Electrolytes 41
CLIA Quality Control (QC) Requirements for Blood Gas Analysis 41
Market Size 42
TABLE 13 FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 43
FIGURE 8 FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING MARKET BY REGION, 2007-2014 ($ MILLIONS) 43
Market Participants and Market Shares 43
TABLE 14 RELATIVE MARKET SHARE OF POC BLOOD CHEMISTRY ANALYZER MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS) 44
FIGURE 9 RELATIVE MARKET SHARE BLOOD GAS ANALYZER MANUFACTURERS BY COMPANY, 2009 (%) 45
TABLE 15 RECENTLY (2008-2009) CLIA-APPROVED BLOOD CHEMISTRY ANALYZERS 45
Radiometer America, Inc. 46
-- ABL80 FLEX 46
-- NPT7 46
-- RADIANCE STAT Analyzer and Data Management Software 47
Nova Biomedical 47
-- Stat Profile pHOx Product Line 47
TABLE 16 NOVA BIOCHEMICAL POC STAT PROFILE PHOX SERIES BY AVAILABLE TESTS 48
-- Stat Profile CCX Product Line 49
TABLE 17 NOVA BIOCHEMICAL POC STAT PROFILE CCX SERIES BY AVAILABLE TESTS 49
-- Point-of-Care Manager (PDM) 50
-- Cumulative Patient Reports 50
Siemens Healthcare 51
-- RAPIDPoint 400/405 51
-- RAPIDComm Data Management System 51
Roche Diagnostics 52
-- Cobas b 121 System 52
-- Cobas b 221 Blood Gas System 52
Abbott Diagnostics 52
-- i-STAT 52
International Technidyne Corp. (ITC) 53
-- IRMA TRUpoint Blood Analysis System 53
-- AVOXimeter Whole Blood Co-Oximeter/Oximeter System 53
CARDIAC MARKER TESTING 53
Market Size 53
TABLE 18 FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 54
FIGURE 10 FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET BY REGION, 2007-2014 ($ MILLIONS) 54
Market Participants and Market Shares 55
TABLE 19 RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS) 55
FIGURE 11 RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS BY COMPANY, 2009 (%) 55
Inverness Medical Innovations 56
-- Triage System 56
Roche 57
-- Cardiac Reader System 57
Abbott 57
-- iSTAT 1 57
Response Biomedical 58
-- RAMP System 58
CHOLESTEROL TESTING 58
Market Size 59
TABLE 20 FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 59
FIGURE 12 FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET, 2007-2014 ($ MILLIONS) 60
Market Participants and Market Shares 60
TABLE 21 RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 61
FIGURE 13 RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 61
TABLE 22 RECENTLY (2008-2009) CLIA-APPROVED CHOLESTEROL TESTS 62
Inverness Medical Innovations 62
Roche Diagnostics 62
Abaxis 62
DRUG AND ALCOHOL ABUSE TESTING 63
Market Size 63
TABLE 23 FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 64
FIGURE 14 FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET BY REGION, 2007-2014 ($ MILLIONS) 64
Market Participants and Market Shares 64
TABLE 24 RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS) 65
FIGURE 15 RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 66
TABLE 25 RECENTLY (2008-2009) CLIA-APPROVED POC DRUG AND ALCOHOL SCREENING TESTS BY MANUFACTURER 66
TABLE 25 (CONTINUED) 67
Inverness Medical Innovations 67
Phamatech 68
Psychemedics 68
Orasure Technologies 68
GLUCOSE TESTING 69
Market Size 70
TABLE 26 FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 71
FIGURE 16 FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET BY REGION, 2007-2014 ($ MILLIONS) 71
TABLE 27 MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY COMPONENT, 2009 ($ MILLIONS) 72
FIGURE 17 MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY COMPONENT, 2009 (%) 72
Market Participants and Market Shares 72
TABLE 28 RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS BY COMPANY, 2009 (PERCENT/$ MILLIONS) 73
FIGURE 18 RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS BY COMPANY, 2009 (%) 73
TABLE 29 RECENTLY (2008-2009) APPROVED CLIA-WAIVED BLOOD GLUCOSE METERS BY MANUFACTURER 74
TABLE 29 (CONTINUED) 75
TABLE 29 (CONTINUED) 76
TABLE 29 (CONTINUED) 77
Roche Diagnostics 77
-- Accu-Chek Active System 77
-- Accu-Chek Inform System 77
-- Accu-Chek Inform II 78
-- Accu-Chek Voicemate System 78
Johnson and Johnson 78
-- LifeScan - OneTouch Ultra Meter 79
-- LifeScan - OneTouch Ultra 2 Meter 79
-- LifeScan OneTouch UltraSmart Meter 79
-- LifeScan OneTouch InDuo System 80
-- LifeScan OneTouch Basic Meter 80
-- LifeScan OneTouch SureStep Meter 80
-- LifeScan OneTouch UltraLink Meter 81
-- LifeScan OneTouch Diabetes Management Software 81
Abbott Diabetes Care 81
-- FreeStyle Blood Glucose Monitoring System 82
-- Precision Xtra Blood Glucose and Ketone Monitoring System 82
-- i-STAT 1 83
Home Diagnostics, Inc. 83
-- Sidekick Testing System 83
-- TrueTrack Smart System 83
-- Prestige IQ Blood Glucose Monitor 84
TABLE 30 SELECTED LISTING OF RETAILERS SELLING HOME DIAGNOSTIC'S METERS 84
Data Management Systems 84
TABLE 31 SELECTED LISTING OF BLOOD GLUCOSE MONITORS CAPABLE OF INTERACTING WITH COMPUTER SOFTWARE BY COMPANY 85
INFECTIOUS DISEASE TESTING 85
Strep A 86
TABLE 32 RECENTLY (2008-2009) CLIA-APPROVED STREP A TESTS BY MANUFACTURER 86
Influenza 86
TABLE 33 RECENTLY (2008-2009) CLIA-APPROVED INFLUENZA TESTS BY MANUFACTURER 87
Chlamydia/Trichomonas 87
RSV 88
TABLE 34 RECENTLY (2008-2009) CLIA-APPROVED RSV TESTS BY MANUFACTURER 88
HIV Testing 88
Inverness Medical 88
OraSure 89
Trinity Biotech, plc 89
Infectious Mononucleosis 89
TABLE 35 RECENTLY (2008-2009) CLIA-APPROVED INFECTIOUS MONONUCLEOSIS TESTS 89
H. pylori 90
TABLE 36 RECENTLY (2008-2009) CLIA-APPROVED H. PYLORI TESTS BY MANUFACTURER 90
Market Size 90
TABLE 37 FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 91
FIGURE 19 FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET BY REGION, 2007-2014 ($ MILLIONS) 91
TABLE 38 MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2009 ($ MILLIONS) 92
FIGURE 20 MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2009 (%) 92
Market Participants and Market Shares 93
TABLE 39 RELATIVE MARKET SHARE OF INFECTOUS DISEASE POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 93
FIGURE 21 RELATIVE MARKET SHARE OF INFECTIOUS DISEASE POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 94
Strep A 94
Influenza 94
Chlamydia 95
PREGNANCY AND FERTILITY TESTING 95
Market Size 95
TABLE 40 FORECAST OF THE GLOBAL PREGNANCY/FERTILITY POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 96
FIGURE 22 FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 96
TABLE 41 MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2009 (PERCENT/$ MILLIONS) 97
FIGURE 23 MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2009 (%) 97
Market Participants and Market Shares 97
TABLE 42 RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 98
FIGURE 24 RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 98
TABLE 43 RECENT (2008-2009) CLIA APPROVED PREGNANCY TESTS BY MANUFACTURER 99
TABLE 43 (CONTINUED) 100
HEMOGLOBIN/HEMOSTASIS 100
Hematology and Hemostasis 100
Hemostasis (Coagulation) 101
Market Size 101
TABLE 44 FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 102
FIGURE 25 FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MARKET BY REGION, 2007-2014 ($ MILLIONS) 102
Market Participants and Market Shares 102
TABLE 45 RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 103
FIGURE 26 RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 103
TABLE 46 RECENTLY (2008-2009) CLIA APPROVED HEMATOLOGY TESTS 104
TUMOR MARKER TESTING 104
Fecal and Gastric Occult Blood 104
Bladder Tumor Antigen Test 104
Market Size 104
TABLE 47 FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 105
FIGURE 27 FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 105
Market Participants and Market Shares 106
TABLE 48 RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 106
FIGURE 28 RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS BY COMPANY, 2009 (%) 106
TABLE 49 RECENTLY (2008-2009) CLIA APPROVED FECAL OCCULT BLOOD TESTS BY MANUFACTURER 107
URINE CHEMISTRY TESTING 107
Market Size 107
TABLE 50 FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 108
FIGURE 29 FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET, 2007-2014 ($ MILLIONS) 109
Market Participants and Market Shares 109
TABLE 51 RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS BY COMPANY, 2009 ($ MILLIONS) 110
FIGURE 30 RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS BY COMPANY, 2009 (%) 110
TABLE 52 RECENTLY (2008-2009) CLIA-APPROVED URINE CHEMISTRY ANALYZERS BY MANUFACTURER 111
TABLE 52 (CONTINUED) 112
MISC TESTING 112
Vaginal pH Tests 113
TABLE 53 RECENTLY (2008-2009) CLIA-APPROVED VAGINAL PH TESTS BY MANUFACTURER 113
Thyroid Stimulating Hormone (TSH) Tests 113
TABLE 54 RECENTLY (2008-2009) CLIA-APPROVED TSH TESTS BY MANUFACTURER 113
Male Reproductive Tests 113
TABLE 55 RECENTLY (2008-2009) CLIA-APPROVED MALE REPRODUCTIVE TEST BY MANUFACTURER 113
Chapter-5: TECHNOLOGY APPLICATIONS
BIOSENSORS 114
WHAT ARE BIOSENSORS? 114
Catalytic Sensors 114
Affinity Sensors 115
ELECTRODES 115
WHAT ARE ELECTRODES? 115
What are Electrodes? (Continued) 116
Chapter-6: PATENT ANALYSIS
NUMBER OF RECENTLY ISSUED PATENTS 117
TABLE 56 RESULTS OF U.S. PATENT SEARCH FOR POC CATEGORIES, SEPTEMBER 2008--SEPTEMBER 2009 (NUMBER) 117
FIGURE 31 U.S. PATENTS BY POC CATEGORIES, SEPTEMBER 2008-SEPTEMBER 2009 (NUMBER) 118
ANALYSIS OF PATENT BY SUBJECT 118
TABLE 57 U.S. PATENTS BY SUBJECT AREA, SEPTEMBER 2008 TO SEPTEMBER 2009 (NUMBER) 118
PATENT ASSIGNEES 119
TABLE 58 U.S. PATENT ASSIGNEES, SEPTEMBER 2008 TO SEPTEMBER 2009 (NUMBER) 119
FIGURE 32 U.S. PATENTS BY COUNTRY, SEPTEMBER 2008-SEPTEMBER 2009 (NUMBER) 120
RECENTLY ISSUED PATENTS 120
GLUCOSE METERS 120
HEMATOLOGY 121
Hematology (Continued) 122
COAGULATION ASSAY 123
IMMUNOASSAY 123
HEMATOLOGY 124
Hematology (Continued) 125
Chapter-7: WORLDWIDE POC MARKET
MARKET SIZE 126
TABLE 59 GLOBAL FORECAST (U.S. AND WORLDWIDE) FOR THE POC MARKET, THROUGH 2014 126
TABLE 59 (CONTINUED) 127
FIGURE 33 GLOBAL (U.S. AND WORLDWIDE) FORECAST FOR THE POC MARKET 2009 AND 2014 ($ MILLIONS) 127
GLOBAL MARKET SHARES 128
TABLE 60 POC GLOBAL MARKET SHARE BY COUNTRY, 2009 (PERCENT/$ MILLIONS) 128
FIGURE 34 POC GLOBAL MARKET SHARE BY COUNTRY, 2009 (%) 129
PRESENCE OF MANUFACTURERS IN THE WORLDWIDE MARKET 129
TABLE 61 MARKET SHARE OF TOP 10 POC MARKET PARTICIPANTS, 2009 ($ MILLIONS) 130
FIGURE 35 MARKET SHARE OF TOP 10 POC MARKET PARTICIPANTS, 2009 (%) 131
Chapter-8: PROFILES OF MAJOR MARKET PARTICIPANTS
OVERVIEW OF MARKET PARTICIPANTS 132
COMPANY PROFILES 132
ABAXIS 132
TABLE 62 ABAXIS' COMPANY REVENUES, 2007-2010* ($ MILLIONS) 133
ABBOTT LABORATORIES 134
TABLE 63 ABBOTT'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 135
BECTON, DICKINSON, & CO. 135
TABLE 64 BD'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 136
DANAHER CORP./RADIOMETER 136
TABLE 65 DANAHER'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 137
INTERNATIONAL TECHNIDYNE CORP. 137
TABLE 66 THORATEC'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 138
INVERNESS MEDICAL INNOVATIONS 138
TABLE 67 INVERNESS MEDICAL'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 139
JOHNSON & JOHNSON 139
TABLE 68 JOHNSON & JOHNSON'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 140
NOVA BIOMEDICAL 140
ORASURE TECHNOLOGIES 140
OraSure Technologies (Continued) 141
TABLE 69 ORASURE'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 142
QUIDEL CORP. 142
TABLE 70 QUIDEL'S COMPANY REVENUES, 2006-2009 ($ MILLIONS) 143
ROCHE 143
TABLE 71 ROCHE GROUP'S REVENUES, 2006-2009 ($ MILLIONS) 144
SIEMENS MEDICAL SOLUTIONS 144
TABLE 72 SIEMENS' COMPANY REVENUES, 2006-2009 ($ MILLIONS) 145
Chapter-9: APPENDIX
APPENDIX 146
KEY SOURCES OF INFORMATION 146
ABAXIS 146
ABBOTT LABORATORIES 146
BECKMAN COULTER, INC. 146
CHURCH & DWIGHT CO., INC. 146
CLINICAL DIAGNOSTICS DIVISION 146
BECTON DICKINSON & CO. 147
HEMOCUE AB 147
HENRY SCHEIN, INC. 147
HOME DIAGNOSTICS, INC. 147
INTERNATIONAL TECHNIDYNE CORP. 147
INVERNESS MEDICAL INNOVATIONS 147
JOHNSON & JOHNSON 148
NOVA BIOMEDICAL 148
ORASURE TECHNOLOGIES 148
PHAMATECH, INC. 148
PSS WORLD MEDICAL, INC. 148
PSYCHEMEDICS CORP. 148
QUEST DIAGNOSTICS 149
QUIDEL CORP. 149
RADIOMETER AMERICA, INC. 149
RESPONSE BIOMEDICAL CORP. 149
ROCHE 149
SIEMENS MEDICAL SOLUTIONS 150
TRINITY BIOTECH, PLC 150
To order this report:
Diagnostics Industry: Point of Care Diagnostics
More Market Research Report
Contact:Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
